연구용제품Bio resource > Vector
Anti-Mesothelin NK CAR Lentiviruses
이츠바이오
Cancer remains one of the leading causes of death in developed countries. Standard treatments such as chemotherapy and surgery can often be invasive or high risk to patients and, by themselves can result in subpar success rates. As an alternative treatment, immune cell therapies have shown promising results in recent clinical trials.
Chimeric antigen receptors (CAR) have demonstrated significantly enhanced anti-tumour activity when expressed in immune effector cells such as T cells. Additionally, CARs can be optimized for expression in natural killer (NK) cells which are responsible for innate immunity. In contrast to CAR-T cells, the NK CAR cells do not require human leukocyte antigen (HLA) matching and therefore do not need to be collected from a patient or donor. This would allow for NK CAR cell therapies to be standardized and widely applicable.
abm offers ten variants of NK CAR lentiviruses which can be used to create NK CAR expressing NK cells. These cells target mesothelin – an antigen which is highly expressed on tumours commonly observed in ovarian, lung and pancreatic cancers.
Anti-Mesothelin-NK-CAR Lentivirues | ||||
---|---|---|---|---|
Product | Cat No. | Quantity | ||
Anti-Mesothelin (SS1) TCAR Lentivirus | LVP750 | 108 IU/ml; 550 µl, | ||
Anti-Mesothelin (SS1) CAR1 Lentivirus | LVP751 | 108 IU/ml; 550 µl, | ||
Anti-Mesothelin (SS1) CAR2 Lentivirus | LVP752 | 108 IU/ml; 550 µl, | ||
Anti-Mesothelin (SS1) CAR3 Lentivirus | LVP753 | 108 IU/ml; 550 µl, | ||
Anti-Mesothelin (SS1) CAR4 Lentivirus | LVP754 | 108 IU/ml; 550 µl, | ||
Anti-Mesothelin (SS1) CAR5 Lentivirus | LVP755 | 108 IU/ml; 550 µl, | ||
Anti-Mesothelin (SS1) CAR6 Lentivirus | LVP756 | 108 IU/ml; 550 µl, | ||
Anti-Mesothelin (SS1) CAR7 Lentivirus | LVP757 | 108 IU/ml; 550 µl, | ||
Anti-Mesothelin (SS1) CAR9 Lentivirus | LVP758 | 108 IU/ml; 550 µl, | ||
Anti-Mesothelin (SS1) CAR10 Lentivirus | LVP759 | 108 IU/ml; 550 µl, |
또한 abm 에서는 400종류 이상의 Immortalized Cells 뿐만 아니라 300종류 이상의 Drug Discovery Cell Lines 및CRISPR Cell Lines 도 제공 하고 있으니 많은 관심 부탁 드립니다.
T : 02 3462 8658 F : 02 3462 8659 e-mail : info@itsbio.co.kr |
본 정보는 "이츠바이오" (으)로 문의 바랍니다.